Latest News

Radcliffe Group Celebrates Strong Growth in Impact Factors Across Its Open Access Journals
Written by: Radcliffe Cardiology
Radcliffe Group Celebrates Strong Growth in Impact Factors Across Its Open Access Journals
THT 2025 Conference Announces its Late-Breaking Scientific Sessions
Written by: THT
THT 2025 Conference Announces its Late-Breaking Scientific Sessions
Neutral Outcomes of Routine Colchicine and Spironolactone Treatments in MI Patients
Written by: Radcliffe Cardiology
CLEAR-SYNERGY: Neutral Outcomes of Routine Colchicine and Spironolactone Treatments in MI Patients
ESC Congress 2024 Unveils its Hot Line Trials
Written by: ESC Congress
ESC Congress 2024 Unveils its Hot Line Trials
Late breaking Clinical Trial Data Addressing Cardiovascular Outcomes in Patients with Diabetes presented at American College of Cardiology Congress
Written by: Radcliffe Cardiology
Late breaking Clinical Trial Data Addressing Cardiovascular Outcomes in Patients with Diabetes presented…
Long-Term Survival Benefit Associated with CRT-D Compared to ICD in HF in the RAFT Trial
Written by: Radcliffe Cardiology
Long-Term Survival Benefit Associated with CRT-D Compared to ICD in HF in the RAFT Trial
Findings from an Apolipoprotein B-Based Genetic Analysis
Written by: Radcliffe Cardiology
New Study Finds Lipoprotein(a) More Atherogenic Compared to LDL
AHA 2023 Late-Breaking Science Lineup Revealed
Written by: AHA
AHA 2023 Late-Breaking Science Lineup Revealed
TCT 23: Late-Breaking Clinical Trials Revealed
Written by: Radcliffe Cardiology
TCT 23: Late-Breaking Clinical Trials Revealed
Latest AI technology improves echocardiogram reproducibility and repeatability
Written by: EchoNous
Latest AI technology improves echocardiogram reproducibility and repeatability

External news

Written by: Medscape
Hyponatremia: Is Rapid Correction a Risk or Relief?
Written by: Medscape
Overlooking Early Cardiogenic Shock Leads to Poor Outcomes
Written by: Medscape
Nighttime Dosing May Provide Better Blood Pressure Control
Written by: Medscape
Make Smoking Cessation Counseling a Routine Intervention
Written by: Medscape
Can Orforglipron ACHIEVE the Unattainable?
Written by: Medscape
Not Just Pills — Cardiologists Must Talk Spirituality
Written by: Medscape
Behind Icons IV: The Genius Code in Einstein’s Brain
Written by: Medscape
Popular HIV Drug Linked to Higher Risk for MACE
Written by: Cardiac Vascular News
Cardio Diagnostics Enters Into an Agreement with AGEPHA Pharma to Advance Precision Assessment and Management of Inflammation Associated with Coronary Heart Disease
Written by: Cardiac Vascular News
Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy to Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)